{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 53,
        "end": 59
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 108,
        "end": 118
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 169,
        "end": 179
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 185,
        "end": 191
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 185,
        "end": 201
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "18754843_2",
  "text": "AIMS : The objectives were to evaluate the effect of CYP2D6 genetic polymorphism on the pharmacokinetics of flecainide , and also on the extent of drug interaction with paroxetine as a CYP2D6 inhibitor after a single oral administration in healthy subjects ."
}
